Breaking News & Top Stories4 stories

Health Initiatives and Concerns in Kenya

Kenya's early rollout of injectable HIV prevention drug Lenacapavir and concerns over mysterious disease in Mombasa.

📰 Coverage & Analysis

Kenya picked for early rollout of injectable HIV prevention drug Lenacapavir

Analysis: Kenya has been chosen as one of nine countries for the early rollout of Lenacapavir, an injectable drug for HIV prevention, approved by the World Health Organization (WHO).

KBC Top Stories•1mo ago

Read Full Story

Kenya to roll out long-acting injectable HIV PrEP Lenacapavir by Jan 2026

Analysis: Kenya plans to launch the long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) Lenacapavir by January 2026 after its approval from the World Health Organization.

Capital News•1mo ago

Read Full Story

Concern as Mysterious Disease Kills 4 in Mombasa

Analysis: Residents of the Changwame area in Mombasa County are in distress as a mysterious disease has led to the deaths of at least four people within a week, sparking fears of a potential outbreak.

Kenyans•1mo ago

Read Full Story

WHO recommends twice-yearly injectable lenacapavir for HIV prevention

Analysis: The World Health Organization (WHO) has recommended the use of injectable lenacapavir (LEN) twice a year as an innovative pre-exposure prophylaxis (PrEP) for HIV prevention, announced during the 13th International AIDS Society Conference in Kigali, Rwanda.

Capital News•1mo ago

Read Full Story

The Online Kenyan

The Online Kenyan

Health Initiatives and Concerns in Kenya

📰 Coverage & Analysis

Kenya picked for early rollout of injectable HIV prevention drug Lenacapavir

Kenya to roll out long-acting injectable HIV PrEP Lenacapavir by Jan 2026

Concern as Mysterious Disease Kills 4 in Mombasa

WHO recommends twice-yearly injectable lenacapavir for HIV prevention